This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Healthpoint Biotherapeutics Introduces Copay Assistance Program For Collagenase Santyl® Ointment

FORT WORTH, Texas, Feb. 1, 2013 /PRNewswire/ -- Healthpoint Biotherapeutics, a Smith & Nephew business  (LSE: SN, NYSE: SNN), today announced the introduction of a Copay Assistance Program for patients who have been prescribed Collagenase SANTYL ® Ointment and pay more than $50 out-of-pocket for their prescription. Under the program, eligible patients cover the first $50 and Healthpoint will pay up to the next $150 of out-of-pocket costs per prescription. The card can be used for as many as six prescriptions at a retail pharmacy, up to a $900 annual maximum.

"We recognize that healthcare costs are an important consideration today and some patients face difficult choices that could lead them to go without the medicines they need," commented Travis Baugh, President of Healthpoint Biotherapeutics. "That is why we are so pleased to introduce the SANTYL ® Ointment Copay Assistance Program as one means of ensuring patient access to this important therapeutic option for managing often debilitating chronic wounds."

Both insured and uninsured patients may qualify for the Copay Assistance Program, except for prescriptions reimbursed under governmental healthcare programs or where otherwise restricted by law.

Additional information, along with program terms and conditions, are available online at or by calling 1-800-364-4767.

About Collagenase SANTYL ® Ointment

Collagenase SANTYL ® Ointment is a selective enzymatic debriding agent that provides continuous, bioactive removal of necrotic (dead) collagen without harming granulation tissue (collagen-rich tissue which forms in the healing wound). In difficult-to-heal and chronic wounds (such as diabetic, venous and pressure ulcers), there is an ongoing deposition of non-viable tissue that must be continually removed to maintain the readiness of the wound for healing. The process of removing these barriers to healing is called debridement, which can be accomplished through the use of certain enzymes (types of proteins) to liquefy necrotic tissue, thus allowing bioburden (microorganisms contaminating the wound) to be more easily removed from the wound.

Ongoing, active removal of necrotic debris at the cellular level may help wounds progress from the inflammatory phase (defense against infection) to the proliferative phase (spreading of new cells over the wound bed) of healing. By breaking the cycle of inflammation which traps many chronic wounds, SANTYL ® Ointment contributes to the formation of granulation tissue and subsequent epithelialization (regeneration of the epidermis across a wound surface).

Collagenase SANTYL ® Ointment is the only product approved by the FDA for use as an enzymatic debriding agent and is indicated for debriding chronic dermal ulcers (e.g., pressure ulcers, venous ulcers and diabetic ulcers) and severely burned areas. SANTYL ® Ointment contains 250 collagenase units per gram of white petrolatum USP; the enzyme collagenase is derived from the fermentation by Clostridium histolyticum. Occasional slight transient erythema has been noted in surrounding tissue when applied outside the wound. One case of systemic hypersensitivity has been reported after one year of treatment with collagenase and cortisone. For more information, please visit .

About Healthpoint Biotherapeutics

Healthpoint Biotherapeutics is a bioactive business of Smith & Nephew focused on the development and commercialization of novel, cost-effective solutions for dermal repair and regeneration. Its research and development strategy is centered around next-generation bioactive therapies for the treatment of chronic wounds. Currently marketed products include Collagenase SANTYL ® Ointment, OASIS ® Wound Matrix, OASIS ® Ultra Tri-Layer Matrix and REGRANEX ® (becaplermin) Gel 0.01%. Healthpoint Biotherapeutics is also committed to advancing the care and treatment of wounds through support of industry leading continuing education from The Wound Institute ®. To learn more about this comprehensive and award winning educational resource, please visit ®.  Healthpoint Biotherapeutics is a business of Smith & Nephew (LSE: SN, NYSE: SNN), and is based in Fort Worth, Texas. For more information, visit the company website at

HEALTHPOINT and related logo, SANTYL, THE WOUND INSTITUTE, THEWOUNDINSTITUTE.COM and REGRANEX are registered trademarks of Smith & Nephew.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs